IPO registrations (S-1, F-1) · Registrants
Vitae Pharmaceuticals, Inc
- SEC CIK
- 1157602 · filings on EDGAR ↗
- Former names
- Vitae Pharmaceuticals Inc (2005–2008); CONCURRENT PHARMACEUTICALS INC (2003–2004)
- Registration
- Form S-1, first filed 2014-08-12, last 2015-01-20; 2 initial registrations, 7 amendments
- Outcome
- Final prospectus filed 2014-09-24; declared effective 2014-09-24
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Business address
- 502 WEST OFFICE CENTER DR, Fort Washington, PA 19034
- EIN
- 04-3567753
- EDGAR entity type
- operating
- Insiders and CEO pay
- Vitae Pharmaceuticals, Inc on the corporate pages
Offering terms
- Proposed price range
- $11.00–$13.00 per share (S-1/A filed 2014-09-23)
- Final price
- $8.00 per share, below the range (424B4 filed 2014-09-24, an initial public offering)
- Shares sold
- 6,875,000
- Gross proceeds
- $55,000,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol VTAE
- Lead underwriters
- Stifel
- Syndicate
- BMO Capital Markets; JMP Securities; Wedbush Securities
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: Vitae Pharmaceuticals, Llc Fuzzy (name and state)
- Form 5500 plan sponsor: VITAE PHARMACEUTICALS, INC. EXACT (EIN (EXACT))
- SEC filer: Vitae Pharmaceuticals, Inc EXACT (CIK (EXACT))
Filings 15
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2014-08-12 | S-1 | S-1 (registration) | Vitae Pharmaceuticals, Inc | 0001047469-14-006906 ↗ |
| 2014-08-28 | S-1/A | S-1/A (amendment) | Vitae Pharmaceuticals, Inc | 0001047469-14-007234 ↗ |
| 2014-08-29 | S-1/A | S-1/A (amendment) | Vitae Pharmaceuticals, Inc | 0001047469-14-007250 ↗ |
| 2014-09-08 | S-1/A | S-1/A (amendment) | Vitae Pharmaceuticals, Inc | 0001047469-14-007457 ↗ |
| 2014-09-11 | S-1/A | S-1/A (amendment) | Vitae Pharmaceuticals, Inc | 0001047469-14-007542 ↗ |
| 2014-09-22 | S-1/A | S-1/A (amendment) | Vitae Pharmaceuticals, Inc | 0001047469-14-007773 ↗ |
| 2014-09-23 | S-1/A | S-1/A (amendment) | Vitae Pharmaceuticals, Inc | 0001047469-14-007814 ↗ |
| 2014-09-24 | 424B4 | 424B4 (final prospectus) | Vitae Pharmaceuticals, Inc | 0001047469-14-007860 ↗ |
| 2014-09-24 | EFFECT | EFFECT (declared effective) | Vitae Pharmaceuticals, Inc | 9999999995-14-002859 ↗ |
| 2015-01-08 | S-1 | S-1 (registration) | Vitae Pharmaceuticals, Inc | 0001047469-15-000093 ↗ |
| 2015-01-20 | S-1/A | S-1/A (amendment) | Vitae Pharmaceuticals, Inc | 0001047469-15-000287 ↗ |
| 2015-01-22 | EFFECT | EFFECT (declared effective) | Vitae Pharmaceuticals, Inc | 9999999995-15-000178 ↗ |
| 2015-01-23 | 424B1 | 424B1 (final prospectus) | Vitae Pharmaceuticals, Inc | 0001047469-15-000364 ↗ |
| 2015-11-05 | EFFECT | EFFECT (declared effective) | Vitae Pharmaceuticals, Inc | 9999999995-15-002982 ↗ |
| 2016-10-28 | EFFECT | EFFECT (declared effective) | Vitae Pharmaceuticals, Inc | 9999999995-16-006094 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2014-09-23 | S-1/A | registration statement | $11.00–$13.00 | 5,000,000 | - | Nasdaq VTAE | 4 | primary document; range, price line, shares headline, proceeds computed, price outside the range dropped, cover names 4 | document ↗ | |
| 2014-09-24 | 424B4 | final prospectus | $8.00 | 6,875,000 | $55,000,000 | Nasdaq VTAE | 4 | primary document; price sentence, shares headline, proceeds table, cover names 4 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| BARRETT M JAMES | TenPercentOwner | 3 | 2014–2015 | ||
| Barrett Peter | Director | 3 | 2014 | ||
| BARRIS PETER J | TenPercentOwner | 3 | 2014–2015 | ||
| Fratamico Arthur | Officer | Chief Business Officer | 7 | 2014–2016 | |
| Gregg Richard | Officer | Chief Science Officer; Chief Scientific Officer | 9 | 2014–2016 | |
| Gunderson Robert V JR | Director | 6 | 2014–2016 | ||
| Hatfield Jeffrey S. | Director,Officer | Chief Executive Officer | 12 | 2014–2016 | |
| HAYDEN DONALD J JR | Director | 9 | 2014–2016 | ||
| HIRSCH RUSSELL C | TenPercentOwner | 3 | 2014–2015 | ||
| Morris Richard Steven | Officer | Chief Financial Officer | 6 | 2014–2016 | |
| NEA PARTNERS 10 L P | TenPercentOwner | 3 | 2014–2015 | ||
| NEW ENTERPRISE ASSOCIATES 10 L P | TenPercentOwner | 3 | 2014–2015 | ||
| NEWHALL CHARLES W III | Director | 5 | 2014–2015 | ||
| PROSPECT MANAGEMENT CO II LLC | TenPercentOwner | 3 | 2014–2015 | ||
| PROSPECT MANAGEMENT CO LLC | TenPercentOwner | 3 | 2014–2015 | ||
| ROBERTS BRYAN E | Director; Director,TenPercentOwner | 5 | 2014–2016 | ||
| Rowland Charles A Jr | Director | 5 | 2014–2016 | ||
| SANDELL SCOTT D | TenPercentOwner | 3 | 2014–2015 | ||
| SANTINI GINO | Director | 5 | 2014–2016 | ||
| SCHNELL DAVID | TenPercentOwner | 3 | 2014–2015 | ||
| VEF MANAGEMENT III LLC | TenPercentOwner | 2 | 2014 | ||
| VENROCK ASSOCIATES | TenPercentOwner | 2 | 2014 | ||
| VENROCK ASSOCIATES III LP | TenPercentOwner | 2 | 2014 | ||
| VENROCK ENTREPRENEURS FUND III LP | TenPercentOwner | 2 | 2014 | ||
| VENROCK MANAGEMENT III LLC | TenPercentOwner | 2 | 2014 | ||
| PROSPECT VENTURE PARTNERS II LP | TenPercentOwner | 2 | 2014–2015 | ||
| PROSPECT VENTURE PARTNERS LP | TenPercentOwner | 2 | 2014–2015 | ||
| LEONARD JOHN M. | Director | 4 | 2015–2016 | ||
| Bernstein Karen | Director | 4 | 2015–2016 | ||
| Adage Capital Advisors, L.L.C. | TenPercentOwner | 2 | 2016 | ||
| ADAGE CAPITAL PARTNERS GP, L.L.C. | TenPercentOwner | 2 | 2016 | ||
| Adage Capital Partners, L.P. | TenPercentOwner | 2 | 2016 | ||
| Atchinson Robert | TenPercentOwner | 2 | 2016 | ||
| Gross Phillip | TenPercentOwner | 2 | 2016 | ||
| Sable Carole | Officer | Chief Medical Officer | 3 | 2016 | |
| JUNIUS DANIEL M | Director | 3 | 2016 | ||
| Applebaum Scott | Officer | General Counsel | 3 | 2016 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | Vitae Pharmaceuticals, Llc | PA | State business registries | name and state |
| Patent assignee | Vitae Pharmaceuticals, LLC | PA | Patents (USPTO) | name and state |
| SEC filer | Vitae Pharmaceuticals, Inc | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | Vitae Pharmaceuticals, Inc. | PA | Trademarks (USPTO) | name and state |
| Form 5500 plan sponsor | VITAE PHARMACEUTICALS, INC. | EIN (EXACT) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Pharmaceutical Preparations, PA first:
- COLLAGENEX PHARMACEUTICALS INC PA
- ORAPHARMA INC PA
- VICURON PHARMACEUTICALS INC PA
- INOVIO PHARMACEUTICALS, INC. PA
- ADOLOR CORP PA
- PROTARGA INC PA
- Traws Pharma, Inc. PA
- MADRIGAL PHARMACEUTICALS, INC. PA
- PhaseBio Pharmaceuticals Inc PA
- NeuBase Therapeutics, Inc. PA
In other datasets, the same topic (Health) in PA:
- Nonprofit: 445 FOUNDATION (Nonprofits (IRS Form 990))
Interests: Pharmaceutical Preparations · Health